1-5 of 5
Adam D. Cohen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple Myeloma

Shwetha H. Manjunath, Adam D. Cohen, Simon F. Lacey, Megan M. Davis, Alfred L. Garfall, J. Joseph Melenhorst, Russell Maxwell, W. Tristram Arscott, Amit Maity, Joshua A. Jones, John P. Plastaras, Edward A. Stadtmauer, Bruce L. Levine, Carl H. June, Michael C. Milone, Ima Paydar
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (23): 6580–6590.
https://doi.org/10.1158/1078-0432.CCR-21-0308
Published: 01 December 2021
View article titled, The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple Myeloma
Open the PDF for The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

Low-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple Myeloma

Sikander Ailawadhi, Rachael Sexton, Suzanne Lentzsch, Muneer H. Abidi, Peter M. Voorhees, Adam D. Cohen, Eric M. Rohren, Stephen Heitner, Kevin Kelly, Niklas J. Mackler, David M. Baer, Antje Hoering, Brian Durie, Robert Z. Orlowski
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (15): 3969–3978.
https://doi.org/10.1158/1078-0432.CCR-19-1997
Published: 03 August 2020
View article titled, Low-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple Myeloma
Open the PDF for Low-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple Myeloma in another window
Journal Articles

How to Train Your T Cells: Overcoming Immune Dysfunction in Multiple Myeloma

Adam D. Cohen, Noopur Raje, Jessica A. Fowler, Khalid Mezzi, Emma C. Scott, Madhav V. Dhodapkar
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (7): 1541–1554.
https://doi.org/10.1158/1078-0432.CCR-19-2111
Published: 01 April 2020
View article titled, How to Train Your T Cells: Overcoming Immune Dysfunction in Multiple Myeloma
Open the PDF for How to Train Your T Cells: Overcoming Immune Dysfunction in Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

Phase 1 Study of Tabalumab, a Human Anti-B-Cell Activating Factor Antibody, and Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma

Noopur S. Raje, Edward A. Faber, Jr, Paul G. Richardson, Gary Schiller, Raymond J. Hohl, Adam D. Cohen, Andres Forero, Susan Carpenter, Tuan S. Nguyen, Ilaria Conti, Christopher J. Kaiser, Damien M. Cronier, James E. Wooldridge, Kenneth C. Anderson
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (23): 5688–5695.
https://doi.org/10.1158/1078-0432.CCR-16-0201
Published: 30 November 2016
View article titled, Phase 1 Study of Tabalumab, a Human Anti-B-Cell Activating Factor Antibody, and Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma
Open the PDF for Phase 1 Study of Tabalumab, a Human Anti-B-Cell Activating Factor Antibody, and Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma

Don M. Benson, Jr, Adam D. Cohen, Sundar Jagannath, Nikhil C. Munshi, Gary Spitzer, Craig C. Hofmeister, Yvonne A. Efebera, Pascale Andre, Robert Zerbib, Michael A. Caligiuri
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (18): 4055–4061.
https://doi.org/10.1158/1078-0432.CCR-15-0304
Published: 14 September 2015
View article titled, A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma
Open the PDF for A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma in another window